Skip to content

Drug interactions

Secukinumab + Zoster vaccine recombinant

Severity: Minor

Secukinumab and Zoster vaccine recombinant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secukinumab is an immunomodulating biologic that might blunt the immune response to vaccination. The recombinant zoster vaccine is non-live, so it is safe to give, but protection may be somewhat reduced. Evidence for IL-17 inhibitors specifically is limited.

What this interaction means in plain words

Secukinumab and Zoster vaccine recombinant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Immunomodulation by IL-17A blockade may theoretically attenuate vaccine-induced immune responses.

What to do

Give the recombinant (non-live) zoster vaccine when indicated, ideally before starting or at a convenient point in secukinumab therapy. Do not delay needed vaccination solely because of secukinumab.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Secukinumab and Zoster vaccine recombinant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Secukinumab with Zoster vaccine recombinant?

MediHelp rates the interaction as minor. Secukinumab and Zoster vaccine recombinant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Secukinumab is an immunomodulating biologic that might blunt the immune response to vaccination. The recombinant zoster vaccine is non-live, so it is safe to give, but protection may be somewhat reduced. Evidence for IL-17 inhibitors specifically is limited.

How serious is the interaction between Secukinumab and Zoster vaccine recombinant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Give the recombinant (non-live) zoster vaccine when indicated, ideally before starting or at a convenient point in secukinumab therapy. Do not delay needed vaccination solely because of secukinumab.

What other medicines interact with Secukinumab?

MediHelp also lists interactions of Secukinumab with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Secukinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in